ARCHIVES

Amgen Cancels Rilotumumab Trials in Gastric Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007

Nobelist Offer “Electronic” Theory Of Cancer

June 27, 1975

Dingell: “Unable To Vouch” For Staff Report On NCI’s Gallo

February 10, 1995

In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored

August 16, 1974

Democrats Say Bush Budget Neglects NSF And NASA.

March 23, 2001

NCI, EORTC Offer Support For Russian Cancer Researchers

April 14, 1995